
Renata Limited (formerly Pfizer Limited) is one of the leading and fastest-growing pharmaceutical and animal health product companies in Bangladesh. The company started its operations as a subsidiary of Pfizer Limited in 1972. For the next two decades, it continued as a highly successful subsidiary of Pfizer Corporation. However, by the late 1990s, the focus of Pfizer had shifted from formulations to research. Per this transformation, Pfizer divested its interests in many countries, including Bangladesh. In 1993 Pfizer transferred the ownership of its Bangladesh operations to local shareholders, and the name of the company was changed to Renata Limited.
The core businesses of Renata Limited are human pharmaceuticals and animal health products. In Bangladesh, it is the 4th largest pharmaceutical company and the market leader in animal health products. It employs over 8,000 people. In addition, Renata products are exported to Afghanistan, Belize, Cambodia, Ethiopia, Guyana, Honduras, Hong Kong, Kenya, Malaysia, Myanmar, Nepal, Philippines, Sri Lanka, Thailand, United Kingdom, and Vietnam. The company is listed on the Dhaka Stock Exchange with over USD 1 billion market capitalization. It contributes about BDT 150 Crores annually to the National Exchequer.
Renata manufactures about 300 generic pharmaceutical products, including hormones, contraceptives, anti-cancer drugs, oral preparations, cephalosporins, parenteral preparations, and other conventional medicines. In addition, they also offer about 95 animal therapeutics and nutrition products.
Renata has ten manufacturing facilities spread over three separate manufacturing sites. Nineteen depots across the country carry out the distribution of its products.
Renata's Headquarters is located in Plot-1, Milk Vita Road, Section-7, Mirpur, Dhaka, Bangladesh. For almost three decades, its medicine has been playing a leading role in the well-being of the people of Bangladesh.